Genetic Analysis releases H1 2026 financial and product updates
Q2 sales reached NOK 5.3 million while EBITDA fell to negative NOK 1 million. The company also launched AInsight, secured a US patent, and expanded into Australia.
See the latest news and media coverage for GA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Human microbiome diagnostics company
genetic-analysis.comLast updated
In short: GA presented IBD diagnostics at UEG Week, secured patents, launched in Australia, and reported H1 2026 results.
Q2 sales reached NOK 5.3 million while EBITDA fell to negative NOK 1 million. The company also launched AInsight, secured a US patent, and expanded into Australia.
Revenue grew 60.2% to NOK 3.8 million, with strong GA-map kit sales and pipeline progress.
The meeting is scheduled for 20 May 2026 in Oslo. Agenda includes approval of 2025 accounts, board elections, remuneration, and authorizations for share capital increases and option programs.
The report for the financial year 2025 is available as an attached file and on the company's website.
Norwegian diagnostics company Genetic Analysis has had research results from the development of its microbiome-based GA-map IBD Precision Dx test selected for an oral presentation...
Novogenia AG (ticker symbol: 7V0, formerly Darwin AG), an international healthcare company focused on human genetics and the development of personalized products based on genetic...
For many dealing with irritable bowel syndrome, they're left with more questions than answers. It's...
Some shark species might belong to their own distinct lineage, which is separate from all other sharks, rays and skates, according to a new study...
Track GA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.